Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea M Stringer

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Experimental Pathology|April 6, 2011
Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti ratNoor Al-Dasooqi, Joanne M Bowen, Rachel J Gibson, et al.
Toxicology|January 26, 2010
Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tractJoanne M Bowen, Anna Tsykin, Andrea M Stringer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 5, 2010
Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti ratNoor Al-Dasooqi, Rachel J Gibson, Joanne M Bowen, et al.
Chemotherapy|February 2, 2011
Selection of housekeeping genes for gene expression studies in a rat model of irinotecan-induced mucositisNoor Al-Dasooqi, Joanne M Bowen, Rachel J Gibson, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositisRichard M Logan, Rachel J Gibson, Joanne M Bowen, et al.
Cancer Biology & Therapy|June 7, 2008
Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugsRichard M Logan, Andrea M Stringer, Joanne M Bowen, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 13, 2014
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositisAbdul R Al-Azri, Rachel J Gibson, Joanne M Bowen, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2008
Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?Richard M Logan, Andrea M Stringer, Joanne M Bowen, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 7, 2025
Targeted deletion of Cyp24a1 in the intestine reduces mucosal injury and preserves epithelial proliferation after 5-fluorouracil treatmentPhir C K Thianhlun, Cyan L Sylvester, Rebecca K Sawyer, et al.
Cancer Biology & Therapy|September 21, 2007
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight lossJoanne M Bowen, Andrea M Stringer, Rachel J Gibson, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Experimental Pathology|April 6, 2011
Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti ratNoor Al-Dasooqi, Joanne M Bowen, Rachel J Gibson, et al.
Toxicology|January 26, 2010
Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tractJoanne M Bowen, Anna Tsykin, Andrea M Stringer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 5, 2010
Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti ratNoor Al-Dasooqi, Rachel J Gibson, Joanne M Bowen, et al.
Chemotherapy|February 2, 2011
Selection of housekeeping genes for gene expression studies in a rat model of irinotecan-induced mucositisNoor Al-Dasooqi, Joanne M Bowen, Rachel J Gibson, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositisRichard M Logan, Rachel J Gibson, Joanne M Bowen, et al.
Cancer Biology & Therapy|June 7, 2008
Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugsRichard M Logan, Andrea M Stringer, Joanne M Bowen, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 13, 2014
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositisAbdul R Al-Azri, Rachel J Gibson, Joanne M Bowen, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2008
Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?Richard M Logan, Andrea M Stringer, Joanne M Bowen, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 7, 2025
Targeted deletion of Cyp24a1 in the intestine reduces mucosal injury and preserves epithelial proliferation after 5-fluorouracil treatmentPhir C K Thianhlun, Cyan L Sylvester, Rebecca K Sawyer, et al.
Cancer Biology & Therapy|September 21, 2007
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight lossJoanne M Bowen, Andrea M Stringer, Rachel J Gibson, et al.
Pageof 6